The Role of Metformin in the Management of NAFLD

The Metabolically Benign and Malignant Fatty Liver

(2011) N. Stefan et al.   DIABETES

Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease

(2010) Giovanni Musso et al.   Annual Review of Medicine

Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis

(2010) Dina G. Tiniakos et al.   Annual Review of Pathology-Mechanisms of Disease

Diabetes and risk of incident cancer: a large population-based cohort study in Israel

(2010) Gabriel Chodick et al.   CANCER CAUSES & CONTROL

Nonalcoholic Fatty Liver Disease: A Review and Update

(2010) Jeffrey R. Lewis et al.   DIGESTIVE DISEASES AND SCIENCES

Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study

(2010) G A Garinis et al.   INTERNATIONAL JOURNAL OF OBESITY

A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis

(2010) Jill K. J. Gaidos et al.   LIVER INTERNATIONAL

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Metformin and Weight Loss on Serum Alanine Aminotransferase Activity in the Diabetes Prevention Program

(2010) Jonathan Krakoff et al.   Obesity

Metabolic syndrome and hepatocellular carcinoma

(2009) Abby B. Siegel et al.   CANCER

Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein

(2009) Ling He et al.   CELL

Treatment of nonalcoholic fatty liver disease in children: TONIC trial design

(2009) Joel E. Lavine et al.   Contemporary Clinical Trials

Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease

(2009) Ziya Omer et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategy

(2009) Leigh A. Cantrell et al.   GYNECOLOGIC ONCOLOGY

Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications

(2009) Elisa Fabbrini et al.   HEPATOLOGY

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

(2009) Kittichai Promrat et al.   HEPATOLOGY

Imaging of Nonalcoholic Steatohepatitis: Advantages and Pitfalls of Ultrasonography and Computed Tomography

(2009) Maki Tobari et al.   INTERNAL MEDICINE

Association of Plasma Leptin Concentrations with Adiposity Measurements in Rural Chinese Adolescents

(2009) Shanchun Zhang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study

(2009) Srinivasan Dasarathy et al.   JOURNAL OF HEPATOLOGY

Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children: A Systematic Review

(2009) Piotr Socha et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Adipokines in Nonalcoholic Steatohepatitis: From Pathogenesis to Implications in Diagnosis and Therapy

(2009) Emmanuel A. Tsochatzis et al.   MEDIATORS OF INFLAMMATION

Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity

(2009) E. Fabbrini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial

(2009) John Willy Haukeland et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease

(2009) Valter Donadon et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease

(2008) A. Nar et al.   ACTA DIABETOLOGICA

Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis

(2008) R. IDILMAN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis

(2008) R. LOOMBA et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Identification and Characterization of Metabolically Benign Obesity in Humans

(2008) Norbert Stefan   ARCHIVES OF INTERNAL MEDICINE

MicroRNA expression pattern in different stages of nonalcoholic fatty liver disease

(2008) X. Jin et al.   DIGESTIVE AND LIVER DISEASE

Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications

(2008) Evanthia Diamanti-Kandarakis   EXPERT REVIEWS IN MOLECULAR MEDICINE

Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

(2008) Vlad Ratziu et al.   GASTROENTEROLOGY

Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis

(2008) Guruprasad P. Aithal et al.   GASTROENTEROLOGY

Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression

(2008) Onpan Cheung et al.   HEPATOLOGY

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

(2008) Raj Vuppalanchi et al.   HEPATOLOGY

Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways

(2008) Keun-Gyu Park et al.   HEPATOLOGY

Non-alcoholic fatty liver disease: The mist gradually clears

(2008) Nimantha Mark Wilfred de Alwis et al.   JOURNAL OF HEPATOLOGY

IGF and Insulin Receptor Signaling in Breast Cancer

(2008) Antonino Belfiore et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

The role of fatty acids in the development and progression of nonalcoholic fatty liver disease

(2008) Christopher L. Gentile et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

(2008) Andrew G Renehan et al.   LANCET

LNA-mediated microRNA silencing in non-human primates

(2008) Joacim Elmén et al.   NATURE

Effect of 6-Month Calorie Restriction and Exercise on Serum and Liver Lipids and Markers of Liver Function

(2008) D. Enette Larson-Meyer et al.   Obesity

Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents

(2008) Kristen J Nadeau et al.   PEDIATRIC DIABETES